simvastatin has been researched along with Anterior Cerebral Circulation Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehsanula, H; Hassan, H; Pattanshetti, M | 1 |
| Chopp, M; Han, Y; Karki, K; Knight, RA; Ledbetter, KA; Seyfried, DM; Yang, D; Zhang, J | 1 |
| Balduini, W; Buonocore, G; Carloni, S; Girelli, S; Longini, M | 1 |
| Han, MK; Lapchak, PA | 1 |
| Granger, DN; Jin, R; Li, G; Liu, L; Nanda, A; Zhu, X | 1 |
| Croxen, RL; Fenstermacher, JD; Knight, RA; Konda, KP; Nagaraja, TN | 1 |
6 other study(ies) available for simvastatin and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Stroke of the inferiomedial temporal lobe causing word agnosia.
Topics: Aged; Agnosia; Brain Infarction; Clopidogrel; Humans; Intelligence Tests; Magnetic Resonance Imaging; Male; Perindopril; Simvastatin; Temporal Lobe; Ticlopidine; Treatment Outcome | 2017 |
Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage.
Topics: Animals; Apoptosis; Atorvastatin; Biomarkers; Brain; Brain Infarction; Bromodeoxyuridine; Cerebral Hemorrhage; Cytoprotection; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microtubule-Associated Proteins; Nerve Degeneration; Neurogenesis; Neuronal Plasticity; Neuropeptides; Neuroprotective Agents; Pyrroles; Rats; Rats, Wistar; Regeneration; Simvastatin; Treatment Outcome | 2009 |
Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Brain; Brain Infarction; Carotid Stenosis; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Enzyme Inhibitors; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Simvastatin; Up-Regulation | 2009 |
Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anticholesteremic Agents; Brain Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Fibrinolytic Agents; Male; Rabbits; rho-Associated Kinases; Simvastatin; Stroke; Time Factors; Tissue Plasminogen Activator | 2010 |
Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice.
Topics: Animals; Anticholesteremic Agents; Apoptosis; Atrophy; Bacterial Infections; bcl-2-Associated X Protein; Brain Infarction; Disease Models, Animal; Humans; Infarction, Middle Cerebral Artery; Infections; Interferon-gamma; Lung; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-bcl-2; Simvastatin; Spleen; Splenectomy; Stroke | 2013 |
Acute neurovascular unit protection by simvastatin in transient cerebral ischemia.
Topics: Aminoisobutyric Acids; Animals; Anticholesteremic Agents; Autoradiography; Blood-Brain Barrier; Brain Edema; Brain Infarction; Capillary Permeability; Carbon Isotopes; Cholesterol; Disease Models, Animal; Functional Laterality; Ischemic Attack, Transient; Male; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury; Simvastatin | 2006 |